Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-26-000201
Filing Date
2026-03-02
Accepted
2026-03-02 16:30:18
Documents
6
Period of Report
2026-04-14

Document Format Files

Seq Description Document Type Size
1 e665189_def14a-immunic.htm DEF 14A 191578
2 GRAPHIC image_001.jpg GRAPHIC 6085
3 GRAPHIC image_002.jpg GRAPHIC 8284
4 GRAPHIC image_003.jpg GRAPHIC 10467
5 GRAPHIC image_006.jpg GRAPHIC 631
6 GRAPHIC image_007.jpg GRAPHIC 3398
  Complete submission text file 0001193805-26-000201.txt   233202
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36201 | Film No.: 26708199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)